INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,888 | +164.7% | 6,650 | +121.2% | 0.00% | – |
| Q2 2023 | $63,437 | +28.9% | 3,007 | +4.1% | 0.00% | – |
| Q1 2023 | $49,222 | -7.1% | 2,889 | +9.7% | 0.00% | – |
| Q4 2022 | $52,993 | -8.6% | 2,634 | -3.5% | 0.00% | – |
| Q3 2022 | $58,000 | +16.0% | 2,730 | +9.2% | 0.00% | – |
| Q2 2022 | $50,000 | -5.7% | 2,500 | +11.8% | 0.00% | – |
| Q1 2022 | $53,000 | -8.6% | 2,236 | +4.5% | 0.00% | – |
| Q4 2021 | $58,000 | +52.6% | 2,140 | +56.4% | 0.00% | – |
| Q3 2021 | $38,000 | +26.7% | 1,368 | +25.2% | 0.00% | – |
| Q2 2021 | $30,000 | -61.0% | 1,093 | -51.0% | 0.00% | – |
| Q1 2021 | $77,000 | +18.5% | 2,232 | +12.7% | 0.00% | – |
| Q4 2020 | $65,000 | +22.6% | 1,981 | +16.5% | 0.00% | – |
| Q3 2020 | $53,000 | +39.5% | 1,701 | +17.9% | 0.00% | – |
| Q2 2020 | $38,000 | +81.0% | 1,443 | +14.6% | 0.00% | – |
| Q1 2020 | $21,000 | – | 1,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |